Preclinical evidence of new opioid modulators for the treatment of addiction

Author： Rodríguez-Arias Marta   Aguilar María Asunción   Manzanedo Carmen   Miñarro José  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.8, 2010-08, pp. : 977-994

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome Proliferator-Activated Receptor (PPAR) Agonists as Promising New Medications for Drug Addiction: Preclinical Evidence

By  

Current Drug Targets, Vol. 14, Iss. 7, 2013-06 ,pp. : 768-776

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 5, 2008-11 ,pp. : 442-453

Bentham Science Publishers

Access to resources Recommend Favorite

New treatment options for opioid dependence

By  

Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Opioid modulators for alcohol dependence

By Hillemacher Thomas   Heberlein Annemarie   Muschler Marc AN   Bleich Stefan   Frieling Helge  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1073-1086

Informa Healthcare

Access to resources Recommend Favorite

Pain and Opioid Addiction: A Systematic Review and Evaluation of Pain Measurement in Patients with Opioid Dependence on Methadone Maintenance Treatment

By  

Current Drug Abuse Reviews, Vol. 9, Iss. 1, 2016-04 ,pp. : 49-60

Bentham Science Publishers

Access to resources Recommend Favorite